CLAY COHEN to Humans
This is a "connection" page, showing publications CLAY COHEN has written about Humans.
Connection Strength
0.386
-
High Rates of Post-Tonsillectomy Hemorrhage in Children With von Willebrand Disease. Pediatr Blood Cancer. 2026 Jan; 73(1):e32101.
Score: 0.026
-
Management of neonatal and infant aortic thrombosis: A single-center case series. Pediatr Blood Cancer. 2024 Nov; 71(11):e31283.
Score: 0.024
-
Nutritional Strategies for Managing Iron Deficiency in Adolescents: Approaches to a Challenging but Common Problem. Adv Nutr. 2024 05; 15(5):100215.
Score: 0.023
-
Emicizumab use in infancy: A survey of United States Pediatric Hemophilia Treatment Center Medical Directors. Haemophilia. 2024 May; 30(3):848-851.
Score: 0.023
-
Intravenous iron therapy in pediatrics: who should get it and when is the right time? Hematology Am Soc Hematol Educ Program. 2023 12 08; 2023(1):630-635.
Score: 0.023
-
Bleeding outcomes and management of supratherapeutic episodes secondary to warfarin in children: A single center 10-year experience. Thromb Res. 2023 08; 228:148-150.
Score: 0.022
-
Adolescent acquired thrombotic thrombocytopenic purpura: An analysis of the Pediatric Health Information System database. Thromb Res. 2023 02; 222:63-67.
Score: 0.021
-
A preventable death: Fatal stroke due to severe iron deficiency anemia. Pediatr Blood Cancer. 2023 03; 70(3):e30014.
Score: 0.021
-
Pulmonary embolism in pediatric and adolescent patients with COVID-19 infection during the SARS-CoV-2 delta wave. Pediatr Blood Cancer. 2022 08; 69(8):e29721.
Score: 0.020
-
Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation. Sci Rep. 2021 11 08; 11(1):21852.
Score: 0.020
-
Emicizumab in pediatric hemophilia: Bleeding and surgical outcomes from a single-center retrospective study. Pediatr Blood Cancer. 2021 11; 68(11):e29325.
Score: 0.020
-
Diagnosis, Clinical Characteristics, and Treatment Modalities of Adolescent May-Thurner Syndrome-associated Deep Venous Thrombosis. J Pediatr Hematol Oncol. 2021 04 01; 43(3):e346-e350.
Score: 0.019
-
Clinical characteristics and outcomes of combined thrombolysis and anticoagulation for pediatric and young adult lower extremity and inferior vena cava thrombosis. Pediatr Hematol Oncol. 2021 Sep; 38(6):528-542.
Score: 0.019
-
Patient Characteristics and Treatment Outcomes of Symptomatic Catheter-Related Arterial Thrombosis in Infants: A?Retrospective Cohort Study. J Pediatr. 2021 04; 231:215-222.
Score: 0.019
-
Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts. Sci Rep. 2020 02 06; 10(1):2005.
Score: 0.018
-
First case of neutropenia and thrombocytopenia in the setting of cerebral cavernous malformation 3. Int J Hematol. 2019 Jul; 110(1):95-101.
Score: 0.016
-
Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department With Fever and Neutropenia: Efficacy and Barriers. Pediatr Emerg Care. 2016 Nov; 32(11):739-745.
Score: 0.014
-
Cerebral Sinus Venous Thrombosis in Pediatric Acute Lymphoblastic Leukemia: Incidence, Clinical Characteristics, and Long-term Neurologic Outcomes. J Child Neurol. 2024 Nov; 39(13-14):494-499.
Score: 0.006
-
Standardizing the evaluation and management of iron deficiency anemia secondary to heavy menstrual bleeding in the emergency department. Pediatr Blood Cancer. 2024 Oct; 71(10):e31222.
Score: 0.006
-
Traumatic intracranial hemorrhage in pediatrics: Implications of factor XIII deficiency and consumptive coagulopathy in abusive head trauma evaluation. Child Abuse Negl. 2024 03; 149:106651.
Score: 0.006
-
Clinical care of pediatric patients with or at risk of postthrombotic syndrome: guidance from the ISTH SSC Subcommittee on pediatric and neonatal thrombosis and hemostasis. J Thromb Haemost. 2024 02; 22(2):365-378.
Score: 0.006
-
COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents. Pediatr Blood Cancer. 2022 06; 69(6):e29681.
Score: 0.005
-
Arterial thrombosis in a newborn with homozygous plasminogen activator inhibitor-1 4G/4G polymorphism. Pediatr Blood Cancer. 2022 08; 69(8):e29586.
Score: 0.005
-
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 2021 07 15; 138(2):190-198.
Score: 0.005